Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.57%498.33B | 10.16%2.36T | 0.94%501.18B | -3.68%2.14T | -14.95%556.06B | -10.55%498.08B | 2.58%588.79B | 13.69%496.52B | 27.42%2.22T | 19.63%653.79B |
| Cost of revenue | -3.29%436.48B | 14.47%2.16T | 13.89%451.33B | -17.86%1.88T | -7.43%561.18B | -25.94%445.63B | -20.17%481.41B | -18.01%396.31B | 35.38%2.29T | 5.91%606.2B |
| Gross profit | 24.09%61.85B | -21.71%199.57B | -50.26%49.85B | 449.22%254.92B | -110.76%-5.12B | 216.83%52.44B | 469.51%107.38B | 314.88%100.22B | -250.13%-73B | 284.04%47.59B |
| Operating expense | ||||||||||
| Operating profit | 24.09%61.85B | -21.71%199.57B | -50.26%49.85B | 449.22%254.92B | -110.76%-5.12B | 216.83%52.44B | 469.51%107.38B | 314.88%100.22B | -250.13%-73B | 284.04%47.59B |
| Net non-operating interest income (expenses) | -10.98%-6.96B | 24.79%-22.8B | 0.77%-6.28B | -14.02%-30.31B | -37.90%-11.09B | 72.95%-1.72B | -77.79%-11.17B | -7.10%-6.32B | -9.78%-26.58B | -26.92%-8.04B |
| Non-operating interest income | 26.66%1.07B | 188.47%7.23B | 51.53%844M | 85.02%2.51B | 41.36%687M | 97.23%641M | 130.37%622M | 103.28%557M | 63.45%1.36B | 132.54%486M |
| Non-operating interest expense | 12.84%8.03B | 7.04%30.03B | 3.46%7.12B | 0.42%28.05B | -17.73%7.02B | 6.71%7.12B | 7.31%7.03B | 11.36%6.88B | 11.55%27.94B | 30.29%8.53B |
| Total other finance cost | ---- | ---- | ---- | --4.76B | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | -74.43%871M | -16.67%1.1B | 35.48%3.41B | -14.78%1.32B | 123.75%669M | -85.87%78M | -88.81%-1.94B | 45.65%2.51B | 4.59%1.55B | -66.63%299M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -219.57%-13.49B | -13.49B | 11.28B | 0 | |||||
| Income from associates and other participating interests | -75.09%1.06B | 68.20%19.73B | 14.63%4.26B | 28.98%11.73B | -96.19%80M | 86.15%5.9B | -27.07%2.03B | 258.63%3.72B | 19.42%9.1B | -45.47%2.1B |
| Special income (charges) | 511.31%2.25B | -3,419.66%-18.8B | -159.72%-548M | -122.91%-534M | -118.10%-852M | 118.88%473M | 24.44%56M | -348.24%-211M | 142.12%2.33B | 271.19%4.71B |
| Less:Other special charges | ---2.45B | 1,214.74%10.79B | ---- | -70.28%821M | ---- | ---- | ---- | ---- | 4.15%2.76B | --0 |
| Less:Write off | -64.96%192M | 2,887.80%8B | 159.72%548M | 94.36%-287M | 100.66%31M | -84.05%-473M | -24.44%-56M | 348.24%211M | -276.72%-5.09B | -251.42%-4.71B |
| Other non-operating income (expenses) | 31.50%-87M | 32.15%1.74B | -122.64%-127M | -42.65%1.32B | 97.32%3.9B | -9.27%-5.66B | -16.33%2.52B | -77.48%561M | 194.77%2.3B | 1,008.99%1.97B |
| Income before tax | 16.66%58.99B | -19.74%180.55B | -49.68%50.57B | 408.07%224.96B | -153.29%-25.91B | 193.34%51.52B | 613.66%98.88B | 312.87%100.48B | -385.85%-73.02B | 261.97%48.63B |
| Income tax | -10.98%12.16B | -11.73%50.03B | -52.55%13.66B | 405.79%56.68B | -142.58%-6.27B | 200.97%13.91B | 401.61%20.24B | 325.59%28.8B | -210.47%-18.54B | 953.60%14.72B |
| Net income | 26.90%46.83B | -22.44%130.52B | -48.52%36.9B | 408.85%168.28B | -157.94%-19.65B | 190.81%37.62B | 727.13%78.64B | 308.15%71.68B | -721.42%-54.49B | 219.84%33.91B |
| Net income continuous operations | 26.90%46.83B | -22.44%130.52B | -48.52%36.9B | 408.85%168.28B | -157.94%-19.65B | 190.81%37.62B | 727.14%78.64B | 308.15%71.68B | -721.43%-54.49B | 219.84%33.91B |
| Noncontrolling interests | -67.95%83M | -4.74%1.75B | 17.73%259M | -5.46%1.84B | 4.07%945M | 26.73%422M | -23.85%249M | -41.18%220M | 2.48%1.94B | 19.79%908M |
| Net income attributable to the company | 27.57%46.74B | -22.64%128.77B | -48.72%36.64B | 394.96%166.44B | -162.40%-20.59B | 189.07%37.19B | 709.31%78.39B | 305.27%71.46B | -921.02%-56.43B | 213.59%33B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 27.57%46.74B | -22.64%128.77B | -48.72%36.64B | 394.96%166.44B | -162.40%-20.59B | 189.07%37.19B | 709.31%78.39B | 305.27%71.46B | -921.02%-56.43B | 213.59%33B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 28.80%95.85 | -24.00%260.14 | -50.39%74.42 | 376.47%342.3 | -167.86%-46.62 | 184.48%75.56 | 676.77%163.34 | 300.70%150.02 | -1,327.06%-123.81 | 209.83%68.7 |
| Diluted earnings per share | 28.80%95.85 | -24.00%260.14 | -50.39%74.42 | 376.47%342.3 | -167.86%-46.62 | 184.48%75.56 | 676.77%163.34 | 300.70%150.02 | -1,327.06%-123.81 | 209.83%68.7 |
| Dividend per share | 0 | 100.00%50 | 0 | 25 | 25 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |